Difficulty: Medium
Average Score: 92%
Practice
A 32-year-old G2P1 woman in her third trimester presents to the ambulatory care clinic with dysuria and urgency. Urine is nitrite positive and leukocyte esterase positive. A drug commonly used to treat urinary tract infections is trimethoprim-sulfamethoxazole, but the physician is reluctant to use it. What risk is the physician worried about?
Correct answer
B
Rationale
The correct answer is B) Kernicterus. Trimethoprim-sulfamethoxazole is associated with an increased risk of kernicterus in newborns. This risk is particularly concerning when this medication is used near term or during breastfeeding due to displacement of bilirubin from albumin, potentially leading to severe jaundice and kernicterus in the neonate.
Option A) Gray baby syndrome is associated with chloramphenicol use, not trimethoprim-sulfamethoxazole. Option C) Limb defects are typically associated with teratogenic drugs like thalidomide, not trimethoprim-sulfamethoxazole. Option D) Premature labor is not a known risk associated with trimethoprim-sulfamethoxazole use.
In an educational context, it is crucial for healthcare providers to understand the potential risks and benefits of medications during pregnancy to make informed decisions that prioritize the safety of both the mother and the developing fetus. This case highlights the importance of considering the potential neonatal risks associated with medications prescribed during pregnancy to prevent adverse outcomes.
Option A) Gray baby syndrome is associated with chloramphenicol use, not trimethoprim-sulfamethoxazole. Option C) Limb defects are typically associated with teratogenic drugs like thalidomide, not trimethoprim-sulfamethoxazole. Option D) Premature labor is not a known risk associated with trimethoprim-sulfamethoxazole use.
In an educational context, it is crucial for healthcare providers to understand the potential risks and benefits of medications during pregnancy to make informed decisions that prioritize the safety of both the mother and the developing fetus. This case highlights the importance of considering the potential neonatal risks associated with medications prescribed during pregnancy to prevent adverse outcomes.